Tag Archives: Dementia Research Priorities

Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)

Posted on August 5, 2020 by Dementia and Elderly Care News

Summary The Lancet Commission on Dementia Prevention, Intervention, and Care has updated evidence on modifiable risk factors the prevention of dementia, and the “life-course model of dementia prevention”. There were nine modifiable risk factors for reducing the risk of dementia … Continue reading →

Posted in Commissioning, Depression, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Nutrition, Person-Centred Care, Pharmacological Treatments, Quick Insights, Statistics, Systematic Reviews, UK, Universal Interest | Tagged Ageing Population, Ageing Population Carer Support, Air Pollution, Air Pollution and Risk of Dementia, Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer's Research and Therapy, Alzheimer’s Therapeutic Research Institute: University of Southern California, Barriers to Support, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Blood Pressure, BMJ Publishing Group Ltd, Burden of Multimorbidity, Canada, Capital Medical University (Beijing China), Caring for Family Carers, China, Chinese University of Hong Kong, Chronic Traumatic Brain Injury, Cognitive Decline and Dementia: Risk Reduction, Cumulative Benefit of Reducing Risk Factors, CVDPREVENT: National Primary Care Audit, Daping Hospital, Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia and COVID-19, Dementia and Multimorbidity, Dementia and Sensory Loss, Dementia Policy, Dementia Post-Diagnostic Care and Support, Dementia Prevalence Projections: LMIC Countries, Dementia Prevalence Projections: LMIC Countries (Low and Middle Income Countries), Dementia Prevention, Dementia Research, Dementia Research Priorities, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Department of Hygiene and Epidemiology: University of Ioannina Medical School, Diet and Dementia, Dietary Factors, Excessive Alcohol Consumption, Family Carers, Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), France, Fudan University (Shanghai China), Geriatric Care and Research Organisation (GeriCaRe), Greece, Harvard Medical School, Head Injury, Healthy Ageing, Healthy Ageing 2020 International Conference [Online] (GeriCaRe), Healthy and Active Ageing: Life-Course Approach (WHO), Healthy Lifestyles, Hippocampal Sclerosis Associated with TDP-43 Proteinopathy, Holistic Post-Diagnostic Care, Hong Kong, Huashan Hospital (Shanghai China), Huazhong University of Science and Technology (Wuhan China), Hyperhomocysteinaemia, Increasing Knowledge of Risk and Protective Factors, Journal of Geriatric Care and Research (JGCR), Journal of Neurology, Journal of Neurology Neurosurgery and Psychiatry, Lancet, Lancet Commission on Dementia Prevention Intervention and Care, Lancet Commission on Dementia Prevention Intervention and Care (LCDPIC), Later Life, LCDPIC: Lancet Commission on Dementia Prevention Intervention and Care, Life-Course Approach to Healthy and Active Ageing, Life-Course Model of Dementia Prevention: Twelve Risk Factors, Life-Course Model of Dementia Prevention, Lifestyle Factors, Lifestyle Risk Factors, Lifestyle Weight Management, Limbic-Predominant Age-Related TDP-43 Encephalopathy (LATE), LMICs, Loneliness, Loneliness and Social Isolation, Loneliness Harms Health, Massachusetts General Hospital, Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, McGill Center for Studies in Aging: McGill University, McGill University, MCI: Mild Cognitive Impairment, Medical Research Council, Mediterranean Diet, Midlife Hypertension, Mild Cognitive Impairment (MCI), Modifiable Risk Factors, Mortality Risk Factors, Multidomain Lifestyle Intervention Trials for Dementia Risk Reduction and Prevention, National University of Singapore, Neurological Disorders, Neuroprotective Lifestyles, Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuropsychiatric Symptoms of Alzheimer’s Disease, Obesity, Obesity Risk Factor, Overlapping Risk Factors, PAF Calculations, PAF for 12 Dementia Risk Factors, People With Dementia and Family Carers, Physical Activity and Health Benefits, Physical Activity Before Dementia, Physical Exercise, Physical Exercise Programmes, Physical Inactivity, Population Attributable Fraction (PAFs) of Dementia, Potentially Modifiable Socio-Environmental Risk Factors for Dementia, Preclinical Dementia and Associated Lifestyle Changes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prevention Better Than Cure, Prevention of Dementia, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Prevention Programmes, Preventive Care, Primary Care Cardiovascular Society, Psychiatry of Late Life Social Care and Society: University of Manchester, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Public Health, Public Health Interventions, Purpan University Hospital (Toulouse France), Qingdao Municipal Hospital, Qingdao University (China), Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Reducing the Incidence of Dementia, Risk and Protective Factors, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Risk Factors and Preventive Interventions for Dementia, Risk Reduction of Cognitive Decline and Dementia, School of Public Health: Tongji Medical College, Sedentary Lifestyles, Sensory Impairments, Shanghai Medical College, Singapore, Smoking Cessation, Social Activities, Social Epidemiology, Social Isolation, Supporting Healthy Lifestyles, Supporting People Affected by Dementia, Systematic Reviews and Meta-Analyses, T2DM, Tackling Inequality and Protecting People With Dementia, Third Military Medical University (Chongqing China), Tobacco, Tobacco Cessation, Tobacco Consumption, Traumatic Brain Injury, Traumatic Brain Injury and Subsequent Dementia, Twelve Risk Factor Life-Course Model of Dementia Prevention, Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes: Prevention, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, United States, University Hospital of Montpellier, University of Cambridge, University of Ioannina Medical School, University of Manchester, University of Southern California, University of Toulouse III, USA, Weight Management, Wellcome Trust Behavioural and Clinical Neuroscience Institute: University of Cambridge, World-Wide FINGERS (WW-FINGERS), World-Wide FINGERS Network, Xuan Wu Hospital, Yong Loo Lin School of Medicine: National University of Singapore | Leave a comment

Dementia Moonshot Report: Research Priorities and Costs (Alzheimer’s Research UK)

Posted on January 25, 2020 by Dementia and Elderly Care News

Summary Alzheimer’s Research UK (ARUK) have released a brief report on six research priorities, which are: Achieving earlier detection of diseases which may cause dementia, (ideally by 10-15 years), to enhance development of new treatments / interventions for people most … Continue reading →

Posted in Alzheimer’s Research UK, Charitable Bodies, Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Models of Dementia Care, National, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Accelerating Alzheimer's Research and Drug Development, Accelerating Detection of Disease, Accelerating Detection of Disease (ADD) Challenge, Accelerating Detection of Disease Programme, Alzheimer's and Dementia: Translational Research and Clinical Interventions (TRCI), Alzheimer’s Research UK (ARUK), Alzheimer’s Research UK’s Dementia Attitudes Monitor, Alzheimer’s Research UK’s Drug Discovery Alliance, Awareness, Awareness Raising, Benefits of Detection and Early Intervention, Benefits of Early Detection, Biomarker Development, Biomarkers, Brain Health Clinics, Charity Research Support Fund, Cognitive Function and Ageing Study II, Cross-Funder Review, Dementia Access Taskforce, Dementia Consortium, Dementia Moonshot, Dementia Prevalence, Dementia Prevention, Dementia Research, Dementia Research and Drug Development, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dementia Translational Medicines Accelerator, Dementia: Prevalence and Detection, Dementias Platform UK, DPUK: Dementias Platform UK, Dr Helen Beaumont: Alzheimer’s Research UK Champion, Drug Development for Alzheimer's Disease, Drug Discovery Alliance, Drug Discovery Institutes, Drug Target Validation, Early Detection of Neurodegenerative Diseases, Economic Impact of Dementia, Global Impact of Dementia, Global Leadership, Government Research Funding, Grand Challenge on Artificial Intelligence and Data, Helen Stokes-Lampard: Chair of RCGP, Hilary Evans: Chief Executive of Alzheimer’s Research UK, Impact of Dementia, Impact of Dementia (Statistics), Impact of Dementia in UK, Life Sciences Industrial Strategy, Life-Changing Treatment for Dementia by 2025 (Moonshot Aim), Medical Research Charities, Mike Gooley Trailfinders Charity Prevention and Risk Reduction Fund, Modifiable Risk Factors, Multi-Morbidities, Multi-Morbidity, No Time to Lose: An Action Plan for Dementia (ARUK), Participation in Research, Patient Involvement in Research, Potential Drug Targets, Preclinical Biomarkers and Dementia, Preclinical Biomarkers in Alzheimer's Disease, Professor Jamie Waterall: National Lead for Cardiovascular Disease at Public Health England, Professor Tara Spires-Jones: Alzheimer’s Research UK Grant Review Board, Research Funding, Research Priorities and Funding / Costs, Research Priorities and Networks, Social and Economic Impact of Dementia, Social and Economic Impact of Dementia in UK, Target Robustness Programme, Translational Medicines, Translational Research, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Health Research Funding | Leave a comment

More on the The Lancet Commission on Dementia Prevention, Intervention, and Care (Irish Journal of Psychological Medicine / Lancet)

Posted on September 29, 2019 by Dementia and Elderly Care News

Summary The Lancet Commission on Dementia Prevention, Intervention, and Care has produced recommendations for the prevention of dementia, proposing a “life-course model of dementia prevention” incorporating nine modifiable risk factors for reducing the risk of dementia. The commission also offers recommendations about the pharmacological, … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Charitable Bodies, Commissioning, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Management of Condition, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Ageing Population, Ageing Population Carer Support, Alzheimer's Research UK, Australia, Barriers to Support, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Blood Pressure, Brighton and Sussex Medical School: University of Sussex, Cambridge Institute of Public Health: University of Cambridge, Camden and Islington NHS Foundation Trust, Canada, Center for Innovative Care in Aging: Johns Hopkins University, Centre for Clinical Brain Sciences: University of Edinburgh, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Dementia Studies: University of Manchester, Centre for Dementia Studies: University of Sussex, Centre for Old Age Psychiatric Research (Innlandet Hospital Trust), Centre for Research in Ageing and Cognitive Health: University of Exeter, Centre for the Health Care of Elderly People: Dalhousie University, Cognitive Decline and Dementia: Risk Reduction, Cumulative Benefit of Reducing Risk Factors, Dalhousie University (Halifax; Canada), Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia and Sensory Loss, Dementia Policy, Dementia Prevention, Dementia Research, Dementia Research Centre: University College London, Dementia Research Priorities, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Department of Health Promotion: Tel-Aviv University, Department of Medicine: University of Washington, Department of Neurology and Department of Psychiatry and the Behavioural Sciences: Keck School of Medicine, Department of Psychiatry and Behavioral Sciences: Johns Hopkins Bayview, Department of Psychiatry: University of Michigan, Department Psychosocial and Community Health: University of Washington, Diet and Dementia, Dietary Factors, Division of Psychiatry: University College London, Economic and Social Research Council (ESRC), Faculty of Medicine: University of Oslo, France, Geriatric Medicine: Dalhousie University, Healthy Ageing, Healthy and Active Ageing: Life-Course Approach (WHO), Healthy Lifestyles, Healthy Lifestyles and Public Health Programmes, Healthy Living, Heczeg Institute on Aging: Tel Aviv University, Increasing Knowledge of Risk and Protective Factors, Innlandet Hospital Trust (Norway), Inserm: Unit 1061, Institute of Health and Society: University of Oslo, Institute of Neurology: National Hospital for Neurology and Neurosurgery, Irish Journal of Psychological Medicine, Israel, Johns Hopkins University (Baltimore), Kaiser Permanente Washington Health Research Institute, Keck School of Medicine, La Colombière Hospital, Lancet, Lancet Commission on Dementia Prevention Intervention and Care, Lancet Commission on Dementia Prevention Intervention and Care (LCDPIC), Later Life, LCDPIC: Lancet Commission on Dementia Prevention Intervention and Care, Leonard Davis School of Gerontology: University of Southern California, Life-Course Approach to Healthy and Active Ageing, Life-Course Model of Dementia Prevention, Lifestyle Factors, Lifestyle Risk Factors, Lifestyle Weight Management, Loneliness, Loneliness and Social Isolation, Loneliness Harms Health, Marie Curie Palliative Care Research Department: University College London, Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, MCI: Mild Cognitive Impairment, Medical School: University of Exeter, Mediterranean Diet, Midlife Hypertension, Mild Cognitive Impairment (MCI), Minerva Center for Interdisciplinary Study of End of Life: Tel Aviv University, Modifiable Risk Factors, Mortality Risk Factors, National Ageing Research Institute (Australia) Academic Unit for Psychiatry of Old Age: University of Melbourne, Neurological Disorders, Neuroprotective Lifestyles, Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuropsychiatric Symptoms of Alzheimer’s Disease, Neuropsychiatry - Epidemiological and Clinical Research: La Colombière Hospital, Norway, Norwegian National Advisory Unit on Aging and Health (Norway), Obesity, Obesity Risk Factor, Overlapping Risk Factors, Physical Activity and Health Benefits, Physical Activity Before Dementia, Physical Exercise, Physical Exercise Programmes, Physical Inactivity, Potentially Modifiable Socio-Environmental Risk Factors for Dementia, Preclinical Dementia and Associated Lifestyle Changes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prevention Better Than Cure, Prevention of Dementia, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Prevention Programmes, Preventive Care, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Public Health, Public Health Interventions, Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Reducing the Incidence of Dementia, Research Networks, Resources for Enhancing Alzheimer’s Caregiver Health intervention (REACH), Risk and Protective Factors, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Risk Factors and Preventive Interventions for Dementia, Risk Reduction of Cognitive Decline and Dementia, Sackler Faculty of Medicine: Tel-Aviv University, School of Nursing: University of Washington, School of Public Health: Tel Aviv University, Sedentary Lifestyles, Sensory Impairments, Smoking Cessation, Social Activities, Social Epidemiology, Social Isolation, Socioeconomically Disadvantaged Populations (NIA Health Disparities Populations), Staying Healthy for Longer, STrAtegies for RelaTives (START), Successful Ageing, Supporting Healthy Lifestyles, Supporting People Affected by Dementia, T2DM, Tel Aviv University, Tobacco, Tobacco Cessation, Tobacco Consumption, Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes: Prevention, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, United States, University College London, University of Edinburgh, University of Exeter, University of Manchester, University of Melbourne, University of Michigan, University of Montpellier, University of Oslo, University of Southern California, University of Sussex, University of Washington, University of Washington (Seattle), USA, VA Center for Clinical Management Research (Ann Arbor USA), Vestfold Health Trust (Norway), Weight Management | Leave a comment

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Posted on March 2, 2019 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018 | Leave a comment

Roadmap for Dementia Research (International Journal of Geriatric Psychiatry / Alzheimer’s Society)

Posted on February 26, 2019 by Dementia and Elderly Care News

Summary Moving beyond the concentration upon research devoted to the discovery of pharmacological interventions for the treatment of dementia / Alzheimer’s Disease, the authors instead worked on a roadmap of complementary (non-pharmacological) research ambitions in the areas of prevention, diagnosis, … Continue reading →

Posted in Alzheimer's Society, Charitable Bodies, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, UK, Universal Interest, Wales | Tagged Ageing Population, Ageing Population Carer Support, Alzheimer's Research UK, Alzheimer's Society, Alzheimer’s Society Research Network, Bangor University, Barriers to Support, Brighton and Sussex Medical School: University of Sussex, Cambridge Institute of Public Health: University of Cambridge, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Research in Ageing and Cognitive Health: University of Exeter, Delivery of Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Dementia 2020 Challenge: 2018 Review Phase 1 (DHSC), Dementia Research, Dementia Research Priorities, Dementia Research Proposals, Dementia Services Development Centre: Bangor University, Division of Psychiatry: University College London, Enabling Dementia Workforce to Deliver Improved Practice by Increasing Knowledge and Informing Changes in Practice and Culture, Increasing Knowledge of Risk and Protective Factors, Institute for Ageing: Newcastle University, Institute for Health and Society: Newcastle University, International Journal of Geriatric Psychiatry, Katherine Cowan Consulting Ltd, Kings College London, London School of Economics and Political Science, LSE's Personal Social Services Research Unit (PSSRU), Maximising Benefits to People Living With Dementia and Their Families of Seeking and Receiving a Diagnosis of Dementia, National Dementia Strategies (UK), Newcastle University, Optimising Quality and Inclusivity of Health and Social Care Systems to Support People Affected by Dementia, Personal Social Service Research Unit (PSSRU), Personal Social Services Research Unit (PSSRU): London School of Economics and Political Science, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, PSSRU at LSE, PSSRU: London School of Economics and Political Science, Quality of Life for People Affected by Dementia by Preventing and Treating Negative Consequences of Dementia, Quality of Life for People Affected by Dementia by Promoting Functional Capabilities and Independence, Research Networks, Risk and Protective Factors, Roadmap to Advance Dementia Research by 2025 (Alzheimer’s Society), Roadmap to Advance Dementia Research by 2025: Care, Roadmap to Advance Dementia Research by 2025: Diagnosis, Roadmap to Advance Dementia Research by 2025: Interventions, Roadmap to Advance Dementia Research by 2025: Prevention, School of Clinical Medicine: University of Cambridge, Social Care Workforce Research Unit: King’s College London, Supporting People Affected by Dementia, University College London, University of Cambridge, University of Exeter, University of Exeter Medical School: University of Exeter, University of Sussex | Leave a comment

Who and What is the Dementia Envoy? (WDC / Department of Health)

Posted on March 8, 2016 by Dementia and Elderly Care News

Summary The Prime Minister has appointed David Mayhew as the latest Dementia Envoy. Dennis Gillings was the former World Dementia Envoy. “The envoy works with countries, corporations and leaders from around the world, sharing expertise and promoting research and support … Continue reading →

Posted in Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, For Researchers (mostly), In the News, International, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Academia-Industry Partnerships, Alzheimer’s Research UK (ARUK), British Prime Minister's Office, Challenge on Dementia (David Cameron), Collaborative Projects, Cross-Sector Partnerships, Data Sharing, David Cameron, David Mayhew CBE: Former Chairman of JP Morgan Cazenove, David Mayhew CBE: Vice Chairman of JP Morgan’s Global Investment Bank, David Mayhew CBE: Wellcome Trust Investment Committee, David Mayhew: Chairman of Alzheimer’s Research UK, David Mayhew: Dementia Envoy (2016-), Dementia Challenge, Dementia Consortium, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Friends, Dementia Innovation, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, GAAD: Global Action Against Dementia, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Envoy for Dementia Innovation, Global Outlook, Global Social Investment for Dementia, Government Research Funding, International Collaborations, International Programmes, JP Morgan, Knowledge Translation, Leadership, Partnership, Partnership and Collaboration, Partnership Working, Prime Minister's Challenge on Dementia, Prime Minister's Office, Prime Minister’s Dementia Challenge, Research and Innovation, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, WDC: World Dementia Council, World Alzheimer Report 2014, World Dementia Council, World Dementia Envoy | Leave a comment

Significant Changes at the World Dementia Council? (WDC)

Posted on February 28, 2016 by Dementia and Elderly Care News

Summary There has been reform within the World Dementia Council (WDC). The changes are intended to make this body “more representative” in global terms (if such were possible) and fully independent. The Council now includes a wider range of international … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, Diagnosis, For Researchers (mostly), In the News, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, UK, Universal Interest, World Health Organization (WHO) | Tagged Abuse of Vulnerable Adults, Academia-Industry Partnerships, Academic Research, Alternatives to Antipsychotic Drugs, Alzheimer's Association, Alzheimer’s Disease: Risk Factors, Alzheimer’s Research UK (ARUK), Argentina, ARUK: Alzheimer’s Research UK, Assistive Technology, Associate Members (WDC), Awareness, Awareness Raising, Behavioural Risk Factors, Big Data, Big Data Partnership, Big Pharma, Bill and Melinda Gates Foundation, Biopharmaceutical Companies, Biotechnology, Challenge on Dementia (David Cameron), Charitable Funding, Clinical Trial Efficiencies, Collaboration, Collaborative Projects, Cross-Sector Partnerships, Data Sharing, Dementia Challenge, Dementia Consortium, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Friends, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, Department of Health’s Integrated Development Initiative, Digital Technology, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), Emerging Technology, Enabling Technology, Future Long-Term Care Costs, GAAD: Global Action Against Dementia, Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Outlook, Global Social Investment for Dementia, Government Research Funding, Hilary Doxford: World Dementia Council Member, Indonesia, Information Technology, Innovative Technology, International Collaborations, International Dementia Research Inventories, International Programmes, Interventions for Social Isolation and Loneliness in Men, Investment in Technology, Join Dementia Research, Leveraging Big Data, Lifestyle Risk Factors, Loneliness and Social Isolation, Modifiable Risk Factors, National Institute of Ageing (NIA), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Research, Nigeria, Open Data and Big Data, Organisation for Economic Co-operation and Development (OECD), Partnership and Collaboration, Partnership Working, Philanthropic Funding, Pipeline Databases, Prevention, Prevention of Dementia, Prime Minister’s Challenge On Dementia 2020, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Raj Long: Vice Chair of World Dementia Council, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Stigma, Regulatory Agencies, Regulatory Experts, Research and Development, Research and Innovation, Research Commitment, Research Funding, Resource and Incentives, Restraint and Restrictions, Restraint in Health and Adult Social Care, Risk Factors, Risk Reduction, Risk Reduction (Formerly Termed Prevention by WDC), Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Social Isolation, Stigma, Taiwan, Treatment and Prevention of Dementia, US National Institute on Aging, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO), Yves Joanette: Chair of World Dementia Council | Leave a comment

Government Commitment to the Global Action Against Dementia (WDC / Department of Health)

Posted on November 25, 2015 by Dementia and Elderly Care News

Summary The Department of Health has responded to Raj Long’s Finding a path for a cure for dementia: an independent report into an integrated approach to dementia drug development report, with a Strategy Report and an open letter. There is … Continue reading →

Posted in Alzheimer's Society, Alzheimer’s Research UK, Charitable Bodies, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, Pharmacological Treatments, Quick Insights, UK, Universal Interest, World Health Organization (WHO) | Tagged $100m Dementia Discovery Fund, Academia-Industry Partnerships, Academic Research, Accelerated Access Review, AIFA: Italian Medicines Agency, Alzheimer's Association, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, Attrition Analysis, BfArM: Federal Institute of Drugs and Medical Devices, Bill and Melinda Gates Foundation, Biopharmaceutical Companies, CEOi: Global CEO Initiative on Alzheimer’s Disease, Challenge on Dementia (David Cameron), Charitable Funding, Clinical Trial Efficiencies, Collaboration, Collaborative Projects, Commission Expert Group on Safe and Timely Access to Medicines for Patients (STAMP), Composite End Points, Continuity Plans (WDC and GAAD Agenda), Council for International Organizations of Medical Sciences (CIOMS), Cross-Sector Partnerships, Danish Health and Medicines Authority, Data Sharing, Dementia Challenge, Dementia Consortium, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Integrated Development Initiative, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Department of Health Dementia Challenge, Department of Health’s Integrated Development Initiative, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DKMA: Danish Health and Medicines Authority, EMA: European Medicines Agency, EU Joint Programme on Neurodegenerative Disease Research (JPND), EU’s Neurodegenerative Disease Research Joint Programme (JPND), European Medicines Agency, European Medicines Agency (EMA), European Prevention of Alzheimer's Dementia Consortium (EPAD), First Global Ministerial Conference on Global Action Against Dementia, Foundation Plan Alzheimer’s, GAAD: Global Action Against Dementia, George Freeman MP: Former Life Sciences Minister, Gill Ayling: Deputy Director of Global Action Against Dementia (Department of Health), Global Action Against Dementia, Global Action Against Dementia (GAAD), Global Alzheimer’s Leadership Series (GoALS), Global Alzheimer’s Platform, Global CEO initiative (CEOi) on Alzheimer’s Disease, Global Leadership, Global Ministerial Conference on Global Action Against Dementia (WHO), Global Observatory on Dementia (WHO), Global Outlook, Global Social Investment for Dementia, Government Research Funding, Integrated Development Advisory Group, International Coalition of Medicines Regulatory Agencies, International Collaborations, International Dementia Advisory Platform (IDAP), International Dementia Research Inventories, International Pharmaceutical Regulatory Forum, International Programmes, Italian Medicines Agency, Jane Ellison MP: Parliamentary Under Secretary for Public Health, Joint Programme on Neurodegenerative Disease Research (JPND), JPND: Joint Programme on Neurodegenerative Disease Research, Medical Research Council (MRC), Modelling and Extrapolation, Multilateral Cooperation, National Institute for Health Research (NIHR), National Institute of Ageing (NIA), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Research, NeuroMap, New York Academy of Sciences (NYAS), Observatory on Dementia (WHO), OLS Accelerated Access Review, Organisation for Economic Co-operation and Development (OECD), Partnership and Collaboration, Partnership Working, Philanthropic Funding, Pipeline Databases, Prime Minister’s Challenge On Dementia 2020, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Regulatory Agencies, Regulatory Experts, Research and Development, Research and Innovation, Research Commitment, Research Funding, Resource and Incentives, Risk Benefit Balance, Swiss Medic, University of Newcastle, US National Institute on Aging, WDC: World Dementia Council, WHO Observatory on Dementia, WHO's Global Observatory on Dementia, World Dementia Council, World Health Organisation (WHO) | Leave a comment

Dementia: the R&D Landscape: Mapping UK Dementia Research and Workforce Capacity (RAND Europe / WDC / OHE)

Posted on October 27, 2015 by Dementia and Elderly Care News

Summary The Alzheimer’s Society commissioned RAND Europe to analyse the UK’s dementia research “landscape” and workforce capacity. The following report relates to the state of funding and capacity in dementia research. It covers: An audit of the types of research … Continue reading →

Evidence Versus Mythology: Challenging Cherished Orthodoxies (British Journal of General Practice)

Posted on October 1, 2015 by Dementia and Elderly Care News

Summary A brief communication in the British Journal of General Practice points to recent evidence raising some interesting questions which many might prefer to duck. This “devil’s advocate”-style letter challenges readers to question some supposedly established axioms in modern dementia … Continue reading →

Posted in Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Quick Insights, UK, Universal Interest | Tagged ALSOVA 3-Year Follow-Up, Beck Depression Inventory (BDI), Brent Memory Service, British Journal of General Practice, Caregiver’s Level of Coping, Caregiver’s Mental Health, Caregivers' Health-Related Quality of Life (HRQoL) and Well-Being, Carers' Health-Related Quality of Life (HRQoL) and Well-Being, CDR Scale Sum of Boxes (CDR-sb), Clinical Dementia Rating (CDR), Consortium to Establish a Registry for Alzheimer's Disease Neuropsychological Battery (CERAD-NB), Dementia and Geriatric Cognitive Disorders Extra, Dementia Case Finding, Dementia Case Finding Scheme, Dementia Challenge, Dementia Crusade (sic), Dementia Diagnosis, Dementia Policy, Dementia Research Priorities, Dementia Screening Debate, Department of Primary Care and Population Health: University College London, Diagnosis and Referral, Drug Discovery Programmes, Early Diagnosis, Early Psychosocial Interventions for Dementia, Early Screening, Ethical Considerations, Ethical Issues of Dementia Care, Evidence Versus Mythology, Evidence-Based Medicine, Evidence-Based Policy, Evidence-Based Practice (EBP), General Health Questionnaire (GHQ), General Practice, Generalized Estimating Equations (GEEs), Gnosall Project, GPs, Incentive Payments, Incentives, International Journal of Geriatric Psychiatry, International Psychogeriatrics, Journal of Geriatric Psychiatry and Neurology, Kuopio ALSOVA Study, London, MCI: Mild Cognitive Impairment, Medical Ethics, Memory Clinics, Mild Cognitive Impairment (MCI), Misdiagnosis, Multiple Projectitis, Neuropsychiatric Symptoms of Alzheimer’s Disease, Over-Diagnosis, Overdiagnosis (Speculative Concept), Perverse Incentives, PLoS One, Post-Diagnosis Support, Post-Diagnostic Dementia Support, Potential Harms of Diagnosis, Prevalence of Dementia, Prevention Agenda, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Primum Non Nocere, Quality of Life Research, Quality Premium Payments, Referral to Memory Clinics: Assessment, Risk of Overdiagnosis Associated With Screening, Screening, Screening for Dementia, Sense of Coherence (SOC), Short Version of the CERAD Neuropsychological Battery, Spousal Caregivers (SCs), Steve Iliffe: Professor of Primary Care for Older People; University College London, Target-Driven Behaviour, Target-Driven Priorities, Timely Diagnosis, University College London | Leave a comment

Tag Archives: Dementia Research Priorities

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites